Literature DB >> 19015637

PML tumor suppressor is regulated by HIPK2-mediated phosphorylation in response to DNA damage.

E Gresko1, S Ritterhoff, J Sevilla-Perez, A Roscic, K Fröbius, I Kotevic, A Vichalkovski, D Hess, B A Hemmings, M L Schmitz.   

Abstract

The promyelocytic leukemia (PML) tumor suppressor protein, a central regulator of cell proliferation and apoptosis, is frequently fused to the retinoic acid receptor-alpha (RARalpha) in acute PML. Here we show the interaction of PML with another tumor suppressor protein, the serine/threonine kinase homeodomain-interacting protein kinase (HIPK2). In response to DNA damage, HIPK2 phosphorylates PML at serines 8 and 38. Although HIPK2-mediated phosphorylation of PML occurs early during the DNA damage response, the oncogenic PML-RARalpha fusion protein is phosphorylated with significantly delayed kinetics. DNA damage or HIPK2 expression leads to the stabilization of PML and PML-RARalpha proteins. The N-terminal phosphorylation sites contribute to the DNA damage-induced PML SUMOylation and are required for the ability of PML to cooperate with HIPK2 for the induction of cell death.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19015637     DOI: 10.1038/onc.2008.420

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

Review 1.  PML nuclear bodies.

Authors:  Valérie Lallemand-Breitenbach; Hugues de Thé
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-21       Impact factor: 10.005

Review 2.  PML nuclear bodies: assembly and oxidative stress-sensitive sumoylation.

Authors:  Umut Sahin; Hugues de Thé; Valérie Lallemand-Breitenbach
Journal:  Nucleus       Date:  2014       Impact factor: 4.197

Review 3.  The potential link between PML NBs and ICP0 in regulating lytic and latent infection of HSV-1.

Authors:  Shuai Wang; Jing Long; Chun-fu Zheng
Journal:  Protein Cell       Date:  2012-04-28       Impact factor: 14.870

Review 4.  The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition.

Authors:  Jaclyn R Gareau; Christopher D Lima
Journal:  Nat Rev Mol Cell Biol       Date:  2010-12       Impact factor: 94.444

5.  The WD40-repeat protein Han11 functions as a scaffold protein to control HIPK2 and MEKK1 kinase functions.

Authors:  Stefanie Ritterhoff; Carla M Farah; Julia Grabitzki; Günter Lochnit; Alexander V Skurat; Michael Lienhard Schmitz
Journal:  EMBO J       Date:  2010-10-12       Impact factor: 11.598

6.  Specification of the NF-kappaB transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKK epsilon.

Authors:  Rita Moreno; Jürgen-Markus Sobotzik; Christian Schultz; M Lienhard Schmitz
Journal:  Nucleic Acids Res       Date:  2010-05-27       Impact factor: 16.971

7.  Regulation of the tumor suppressor PML by sequential post-translational modifications.

Authors:  M Lienhard Schmitz; Inna Grishina
Journal:  Front Oncol       Date:  2012-12-31       Impact factor: 6.244

8.  Post-translational modifications of PML: consequences and implications.

Authors:  Xiwen Cheng; Hung-Ying Kao
Journal:  Front Oncol       Date:  2013-01-04       Impact factor: 6.244

Review 9.  The function, regulation and therapeutic implications of the tumor suppressor protein, PML.

Authors:  Dongyin Guan; Hung-Ying Kao
Journal:  Cell Biosci       Date:  2015-11-04       Impact factor: 7.133

10.  HIPK2 catalytic activity and subcellular localization are regulated by activation-loop Y354 autophosphorylation.

Authors:  Francesca Siepi; Veronica Gatti; Serena Camerini; Marco Crescenzi; Silvia Soddu
Journal:  Biochim Biophys Acta       Date:  2013-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.